Longitudinal tumor-wide sampling of glioblastoma reveals diverse genomic drivers of the earliest clonal expansion at diagnosis and recurrence. Efficacy and biomarker analysis of phase 2 (P2) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results